Clearly the market doesn't mind the new personnel. I think what is more important however is that the appointment of a CEO signals an expectation that production is nigh.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025